Search Results - "pharmacokinetics"

Validation of a Liquid Chromatography/Tandem Mass Spectrometry Assay for the Quantification of Plasma Dihydroartemisinin by Dona Arlinda, Intan Sari Oktoberia, Muhammad Karyana

Connect to this object online.

An LC-MS/MS method for simultaneous analysis of the cystic fibrosis therapeutic drugs colistin, ivacaftor and ciprofloxacin by Huiya Yuan, Shihui Yu, Guihong Chai, Junting Liu, Qi (Tony)

Connect to this object online.

Model-based exploration of the rationality of off-label use of cetirizine in Chinese pediatric patients: a prospective cohort study by Wei Liu, Wei Liu, Wei Liu, Zhiyuan Tan, Ping Yang, Ping Yang, Zhiheng Yu, Xueting Yao, Pengxiang Zhou, Pengxiang Zhou, Ling Liu, Wei Zhou

Connect to this object online.

Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen by A. I. Kochetkov, O. D. Ostroumova

Connect to this object online.

Liquid chromatography-mass spectrometry for simultaneous determination of spironolactone and canrenone in plasma samples by Ricardo Ferreira-Nunes, Edson Aliel Teixeira de Almeida, Marcilio Cunha-Filho, Tais Gratieri, Guilherme Martins Gelfuso

Connect to this object online.

Tigecycline Absorption Improved by Selected Excipients by Hubert Ziółkowski, Kalina Szteyn, Dawid Jędrzkiewicz, Bartosz Rasiński, Jerzy Jaroszewski

Connect to this object online.

Antimalarial herbal drugs: a review of their interactions with conventional antimalarial drugs by Earnest Oghenesuvwe Erhirhie, Chidozie Ikegbune, Anthony Ifeanyi Okeke, Chukwunonso Chukwudike Onwuzuligbo, Ngozi Ukamaka Madubuogwu, Uche Maryann Chukwudulue, Onyinye Blessing Okonkwo

Connect to this object online.

Selection of bispecific antibodies with optimal developability using FcRn‑pH‑HPLC as an optimized FcRn affinity chromatography method by Thomas Müller, Carolin Tasser, Michael Tesar, Ivica Fucek, Ute Schniegler-Mattox, Joachim Koch, Kristina Ellwanger

Connect to this object online.

Improvement of Pain Relief of Fentanyl Citrate Drug Encapsulated in Nanostructured Lipid Carrier: Drug Formulation, Parameter Optimization, in vitro and in vivo Studies by Bahrami MA, Farhadian N, Karimi M, Forouzan A, Masoumi K

Connect to this object online.

In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions by Parthena Martin, Maciej Czerwiński, Pallavi B. Limaye, Seema Muranjan, Brian W. Ogilvie, Steven Smith, Brooks Boyd

Connect to this object online.

Protocol: Pentoxifylline optimal dose finding trial in preterm neonates with suspected late onset sepsis (PTX-trial) by Serife Kurul, H. Rob Taal, Robert B. Flint, Jan Mazela, Irwin K. M. Reiss, Karel Allegaert, Sinno H. P. Simons

Connect to this object online.

Biophysics and Physiological Modeling: Model Validation and Penicillin by Peter Nelson

Connect to this object online.

Evaluation of the cytochrome P450 2C19 and 3A4 inhibition potential of the complement factor 5a receptor 1 antagonist ACT‐1014‐6470 in vitro and in vivo by Marion Anliker‐Ort, Jasper Dingemanse, Stephane Delahaye, Luboš Janů, John van denAnker, Benjamin Berger, Priska Kaufmann

Connect to this object online.

The oral bioavailability, excretion and cytochrome P450 inhibition properties of epiberberine: an in vivo and in vitro evaluation by Chen N, Yang X, Guo C, Bi X, Chen J, Chen H, Li H, Lin H, Zhang Y

Connect to this object online.

Fast In Vitro Release and In Vivo Absorption of an Anti-Schizophrenic Drug Paliperidone from Its Soluplus^®/TPGS Mixed Micelles by Ye Zhou, Chenhui Wang, Wenqian Liu, Meiqing Yang, Bohui Xu, Yong Chen

Connect to this object online.

A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCG-refractory and BCG-intolerant patients by Mark Kowalski, Joycelyn Entwistle, Jeannick Cizeau, et al

Connect to this object online.

Bioequivalence Study of Tebipenem Pivoxil in Healthy Chinese Adults by Rui Hao, Yiming Shao, Sisi Lin, Yi Wu, Li Bian, Yiwen Zhang

Connect to this object online.

Evaluation of NTP42, a novel thromboxane receptor antagonist, in a first-in-human phase I clinical trial by Helen M. Reid, Mark Maginn, C. Michael Perkins, Eamon P. Mulvaney, Malcolm Boyce, Takahiro Yamamoto, B. Therese Kinsella

Connect to this object online.

A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia by Caccia S, Invernizzi RW, Nobili A, Pasina L

Connect to this object online.

Enhancement of absorption and bioavailability of echinacoside by verapamil or clove oil by Shen JY, Yang XL, Yang ZL, Kou JP, Li F

Connect to this object online.